Jaguar Health, Inc.
JAGX
$1.02
-$0.14-12.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.57% | -9.64% | -13.42% | -8.18% | -26.69% |
| Total Depreciation and Amortization | -6.54% | -0.54% | -10.49% | 0.34% | -4.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | -28.56% | 51.52% | -11.40% | 7.06% | 374.14% |
| Change in Net Operating Assets | 1,248.88% | 150.24% | 962.09% | 56.76% | 96.82% |
| Cash from Operations | 26.05% | 24.20% | -3.82% | -5.03% | 6.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.95% | -54.26% | -7.21% | 71.97% | -- |
| Issuance of Common Stock | 11.30% | -77.75% | -85.85% | -69.94% | 163.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -533.33% | 55.22% | 59.52% | -102.55% | 10.00% |
| Cash from Financing | 77.31% | -78.89% | -59.52% | -73.43% | 150.53% |
| Foreign Exchange rate Adjustments | -732.26% | 670.00% | 289.47% | -227.27% | 255.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.48% | -179.51% | -144.48% | -262.41% | 48.53% |